Section Arrow
HROW.NASDAQ
- Harrow
Quotes are at least 15-min delayed:2026/02/15 02:50 EST
Regular Hours
Last
 47.69
+0.57 (+1.21%)
Day High 
49.2 
Prev. Close
47.12 
1-M High
50.165 
Volume 
324.25K 
Bid
47.8
Ask
49
Day Low
47.46 
Open
48.17 
1-M Low
40.61 
Market Cap 
1.75B 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 46.46 
20-SMA 45.85 
50-SMA 47.26 
52-W High 54.85 
52-W Low 20.85 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-0.13/1.08
Enterprise Value
1.97B
Balance Sheet
Book Value Per Share
1.27
Cash Flow
Cash Flow Yield
0.01
Income Statement
Total Revenue
199.61M
Operating Revenue Per Share
2.77
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
HIMSHims & Hers Health16.3+0.5+3.16%29.91PE
CGCCanopy Growth Corp1.08+0.05+4.85%-- 
HLNHaleon plc11.2+0.04+0.36%24.53PE
VTRSViatris15.77-0.02-0.13%-- 
AKBAAkebia Therapeutics1.21-0.15-11.03%-- 
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Harrow Inc is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U.S. market. The company helps U.S. eyecare professionals preserve the gift of sightby making its comprehensive portfolio of prescription and non-prescription pharmaceutical products accessible and affordable to millions of Americans. Its operating segments are The Branded segment includes activities of the Company's FDA-approved ophthalmology pharmaceutical products, including the out-licensing of rights to certain of branded products; and The ImprimisRx segment represents activities in the Company's ophthalmology-focused pharmaceutical compounding business.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.